A Study to Assess AFM13 in Patients With Hodgkin Lymphoma
NCT01221571
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Hodgkin Lymphoma
Interventions
DRUG:
AFM 13
Sponsor
Affimed GmbH